Craig
Investment Director
Craig joined Serpentine in 2021 as investment director, and leads our Swiss Diabetes Venture Fund, addressing one of the major healthcare challenges of our time by investing globally in early stage diabetes technology.
Craig previously ran the investment and commercial arm of the AO Foundation, facilitating, identifying, investing in and supporting disruptive healthcare innovation globally. Over the past 25 years he has led people and projects across industries, functions and organizations throughout Europe, the Middle East, Africa, Asia and the Americas, based out of London, Warsaw, Copenhagen and now Zurich.
He is also a mentor and coach at the European Institute of Innovation & Technology, and advises early stage businesses and social ventures on raising capital and going to market.